Compare HUMA & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUMA | CPSS |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 201.5M |
| IPO Year | N/A | 1992 |
| Metric | HUMA | CPSS |
|---|---|---|
| Price | $1.06 | $9.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.13 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 21.9K |
| Earning Date | 11-12-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | $1,571,000.00 | ★ $196,531,000.00 |
| Revenue This Year | N/A | $139.62 |
| Revenue Next Year | $698.97 | $10.58 |
| P/E Ratio | ★ N/A | $11.46 |
| Revenue Growth | N/A | ★ 6.67 |
| 52 Week Low | $0.91 | $6.67 |
| 52 Week High | $5.48 | $12.73 |
| Indicator | HUMA | CPSS |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 51.91 |
| Support Level | $0.91 | $9.07 |
| Resistance Level | $1.17 | $9.44 |
| Average True Range (ATR) | 0.08 | 0.23 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 38.46 | 12.33 |
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.